OraSure Technologies (OSUR) Set to Release Earnings on Monday

Key Points

• OraSure Technologies is expected to report Q3 2026 results after market close on Monday, November 9. Analysts forecast a loss of $0.18 per share and revenue of approximately $31 million.
• OSUR shares opened at $3.94, with a market capitalization of about $271.7 million. The stock has traded between $2.08 and $4.58 over the past year and remains below the consensus price target of $3.00.
• Analyst sentiment is mixed but currently averages a “Hold” rating, with one Strong Buy, two Holds, and one Sell among recent assessments.

OraSure Technologies (NASDAQ:OSUR - Get Free Report) will likely be issuing its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $31.00 million for the quarter. Investors may visit the company's upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Monday, November 9, 2026 at 5:00 PM ET.

OraSure Technologies Price Performance

OSUR opened at $3.94 on Monday. The firm has a market cap of $271.74 million, a PE ratio of -5.71 and a beta of 1.08. The stock has a 50-day moving average price of $3.76 and a 200-day moving average price of $3.51. OraSure Technologies has a 1 year low of $2.08 and a 1 year high of $4.58.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Wall Street Zen upgraded shares of OraSure Technologies from a "sell" rating to a "hold" rating in a research note on Monday, August 10th. Craig Hallum raised shares of OraSure Technologies to a "strong-buy" rating in a report on Friday, October 23rd. Zacks Research upgraded shares of OraSure Technologies to a "hold" rating in a research note on Friday, October 2nd. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of OraSure Technologies in a research note on Tuesday, September 1st. One analyst has rated the stock with a Strong Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $3.00.

About OraSure Technologies

OraSure Technologies, Inc develops, manufactures and markets diagnostic products and specimen-collection technologies used by healthcare providers, laboratories, researchers and consumers. The company focuses on making testing more accessible through products that support decentralized, point-of-care and at-home testing, as well as laboratory-based molecular and diagnostic workflows.

Its portfolio has included the OraQuick line of rapid diagnostic tests, including oral-fluid tests for HIV and hepatitis C, along with other infectious-disease testing products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.